Lataa...

Targeted therapies for ER+/HER2- metastatic breast cancer

The majority of breast cancers present with estrogen receptor (ER)-positive and human epidermal growth factor receptor (HER2)-negative features and might benefit from endocrine therapy. Although endocrine therapy has notably evolved during the last decades, the invariable appearance of endocrine res...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Med
Päätekijät: Yamamoto-Ibusuki, Mutsuko, Arnedos, Monica, André, Fabrice
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462184/
https://ncbi.nlm.nih.gov/pubmed/26059247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0369-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!